81
Participants
Start Date
August 7, 2020
Primary Completion Date
February 9, 2023
Study Completion Date
February 9, 2023
Testosterone Cypionate 200 Mg/ML
Participants in this group will receive intramuscular testosterone cypionate injections of 1 cc (200mg) once every 14 days for four months.
Intranasal Testosterone
Participant in this group will receive Intranasal testosterone administered using a multi-dose dispenser, as two or three daily doses (5.5 mg per nostril, 11.0 mg single dose) for 4 consecutive months,
University of Miami Miller School of Medicine, Miami
Collaborators (1)
Acerus Pharmaceuticals Corporation
INDUSTRY
University of Miami
OTHER